|
MIP-4 (PARC), human recombinant
A chemoattractant for lymphocytes
Product Overview
Alternate Names / Synonyms: Small inducible cytokine A18, CCL18, Macrophage inflammatory protein 4, MIP-4, Pμlmonary and activation-regulated chemokine, CC chemokine PARC, Alternative macrophage activation-associated CC chemokine 1, AMAC-1, Dendritic cell chemokine 1, DC-CK1, chemokine (C-C motif) ligand 18, CKb7, PARC, AMAC1, DCCK1, SCYA18,
Gene Symbol: MIP4
Accession #: P55774
Gene ID: 6362
Source: E. coli
Appearance: Lyophilized protein
Physical Form Description: Sterile filtered and lyophilized with no additives
Molecular Weight: 7.8 kDa
Purity by SDS-PAGE: ≥98%
Purity by HPLC: ≥98%
Endotoxin Level: <0.1 ng/μg
Biological Activity: The biological activity of human MIP-4 was determined by a chemotaxis assay using human T lymphocytes. Significant chemotaxis was achieved at 100 ng/ml.
Reconstitution Instructions: Reconstitute in water to a concentration of 1 mg/ml. The solution can be diluted into other buffered solutions
Storage Temp.: -20°C
Shipping: Blue ice
Background Information: Human microphage inflammatory protein-4 (MIP-4) also known as PARC, has been shown to be chemotactic for T lymphocytes but not for monocytes or granulocytes. BioVision’s human MIP-4 is an 7.8 kDa protein containing 68 amino acid residues.
Handling: Centrifuge the vial prior to opening.
Usage: For Research Use Only! Not to be used in humans. |